Integrate All Intelligence, To Create Radical Cure
DEARGEN advances the treatment of rare and intractable diseases through the integration of AI and collective intelligence.
DearTRANS
Genome data Analysis
WX
Biomarker Prediction
AI-Powered
Target Discovery
DearDTI
Molecule Selection
MolEQ
Lead Optimization
AI-Powered
Drug Design
The AI Platform For Drug Discovery
Dr. UG is an AI platform for developing new drugs that is based on DEARGEN’s deep learning technology. It specializes in genome data analysis, biomarker prediction, molecule selection and optimization. DEARGEN discovers new disease targets with Dr.UG and further realizes precision medicine by designing small molecules for new drugs.
Our Technology Dr.UG
Our Work
Power of Integration
DEARGEN has long been establishing an AI-based new drug development process through operating a cooperative network with experts in new drug development. Our innovative new drug pipeline will allow the radical cure of diseases that have remained difficult to treat.
Our Team
We make it together
We realize Precision Medicine together with experts in Deep learning, Software, Biology and Bioinformatics. Our brilliant Avengers team acts faster than anyone else and consistently moves to face new challenges.
Meet Our Teams
"Let's make a DREAM together"
Kilsoo Kang / CEO
Partners
